2.80
Accendra Health Inc stock is traded at $2.80, with a volume of 1.27M.
It is up +2.19% in the last 24 hours and up +0.00% over the past month.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
See More
Previous Close:
$2.74
Open:
$2.74
24h Volume:
1.27M
Relative Volume:
0.67
Market Cap:
$216.57M
Revenue:
$10.42B
Net Income/Loss:
$-38.77M
P/E Ratio:
-5.4902
EPS:
-0.51
Net Cash Flow:
$323.54M
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
-39.52%
1Y Performance:
-66.75%
Accendra Health Inc Stock (OMI) Company Profile
Name
Accendra Health Inc
Sector
Industry
Phone
(804) 723-7000
Address
10900 NUCKOLS ROAD, GLEN ALLEN, VA
Compare OMI vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OMI
Accendra Health Inc
|
2.80 | 216.57M | 10.42B | -38.77M | 323.54M | -0.51 |
|
MCK
Mckesson Corporation
|
944.65 | 114.55B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
364.92 | 70.03B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
225.18 | 51.83B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
81.25 | 9.54B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.41 | 793.60M | 2.22M | -5.63M | -1.68M | -0.24 |
Accendra Health Inc Stock (OMI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Downgrade | UBS | Buy → Neutral |
| Jul-19-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-12-22 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-12-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-26-22 | Resumed | Citigroup | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-30-22 | Resumed | JP Morgan | Underweight |
| Dec-17-20 | Upgrade | UBS | Neutral → Buy |
| Sep-25-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-05-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Jan-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-10-19 | Reiterated | BofA/Merrill | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-01-18 | Reiterated | Barclays | Underweight |
| Oct-31-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-08-18 | Initiated | Barclays | Underweight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Dec-19-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-01-17 | Upgrade | Robert W. Baird | Underperform → Neutral |
| Nov-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Apr-21-16 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-16-16 | Initiated | Credit Suisse | Underperform |
| Dec-07-15 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Accendra Health Inc Stock (OMI) Latest News
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
AASTOCKS Financial NewsAccendra Health, Inc. (ACH) - AASTOCKS.com
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
ACH (Accendra Health) Interest Coverage : 1.94 (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) EV-to-OCF : -23.35 (As of Jan. 07, 2026) - GuruFocus
ACH (Accendra Health) Current Deferred Revenue : $0 Mil (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) ROCE % : 6.66% (As of Sep. 2025) - GuruFocus
Return on assets % of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView — Track All Markets
ETFs Investing in Accendra Health, Inc. Stocks - TradingView — Track All Markets
ACH Forecast — Price Target — Prediction for 2027 - TradingView — Track All Markets
Accendra Health, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Diluted net income available to common stockholders of Accendra Health, Inc. – BOATS:ACH - TradingView — Track All Markets
Accendra Health (NYSE: OMI) adds pro forma data on P&HS sale - Stock Titan
It’s official: Accendra Health goes live on NYSE, unveils new website - HME News
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
ACH Seasonals Chart - TradingView — Track All Markets
Net current asset value per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Revenue per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc. Financial Disclosures & SEC Filings - TradingView — Track All Markets
Free cash flow per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc.: Target Price Consensus and Analysts Recommendations | 6OM | US6907321029 - MarketScreener
Accendra Health, Inc.: Revenue and Earnings Analysts Forecasts Revisions | 6OM | US6907321029 - MarketScreener
Accendra Health begins trading on NYSE under new ticker symbol By Investing.com - Investing.com Nigeria
Accendra Health Inc (NYSE: ACH)Related Research - intelligentinvestor.com.au
6OM: Static price chart | Accendra Health, Inc. | US6907321029 - MarketScreener
Platinum Equity Completes Acquisition of Owens & Minor Products & Healthcare Services Business - Platinum Equity
Owens & Minor rebrands after $375M sale of largest division - Virginia Business
Two execs exit Accendra Health as Products & Healthcare Services sale closes - HME News
ACH Stock Price Today - Stock Titan
Two new option listings and three option delistings on January 2nd - TipRanks
Owens & Minor (OMI) Options to be Delisted in Early January - GuruFocus
Platinum Equity Completes Acquisition Of Owens & Minor Products & Healthcare Services Business - Pulse 2.0
Accendra Health begins trading on NYSE under new ticker symbol - Investing.com
Accendra Health to Begin Trading on NYSE under New Ticker “ACH” - TradingView — Track All Markets
Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH” - FinancialContent
Accendra Health, Inc.: Top Mutual Funds Holders | OMI | US6907321029 - MarketScreener
Owens & Minor, Inc. will Change its Ticker to ACH from OMI - marketscreener.com
Owens & Minor completes sale of products segment, rebrands as Accendra By Investing.com - Investing.com India
Owens & Minor completes sale, transforms to Accendra Health - MSN
Owens & Minor completes sale of products segment, rebrands as Accendra - Investing.com Nigeria
Owens & Minor completes sale of products & healthcare services business to Platinum Equity - MarketScreener
Accendra Health Inc Stock (OMI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accendra Health Inc Stock (OMI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
| Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 09 '25 |
Buy |
7.39 |
225,000 |
1,662,750 |
11,482,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 08 '25 |
Buy |
7.96 |
105,000 |
835,800 |
11,257,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 10 '25 |
Buy |
7.19 |
80,000 |
575,200 |
11,562,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 07 '25 |
Buy |
7.84 |
240,000 |
1,881,600 |
11,152,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 03 '25 |
Buy |
8.53 |
160,000 |
1,364,800 |
10,784,599 |
| Coliseum Capital Management, L | 10% Owner |
Apr 04 '25 |
Buy |
8.14 |
128,356 |
1,044,818 |
10,912,955 |
| Coliseum Capital Management, L | 10% Owner |
Feb 28 '25 |
Buy |
9.39 |
1,738,511 |
16,324,618 |
9,469,698 |
| Coliseum Capital Management, L | 10% Owner |
Mar 04 '25 |
Buy |
9.75 |
800,000 |
7,800,000 |
10,624,599 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):